To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life (QOL)...

Gli autori si sono posti l’obiettivo di analizzare il valore delle misurazioni della massa tumorale come indicatore prognostico dell’outcome di...

It is still debated whether BPT affects overall (OS) and progression-free survival (PFS). We investigated the incidence of BPT along with possible...

Lo studio ha confermato che il raggiungimento della CR entro 2 anni dalla diagnosi è associato a un miglioramento degli outcome di sopravvivenza e...

Gli autori hanno identificato la filogenesi della popolazione tumorale subclonale e ne hanno ricavato l’architettura evolutiva in ciascun paziente

In summary, our study contributes to growing evidence suggesting that high BMI or obesity may be a risk factor for progression from MGUS to MM...

Our findings suggest that multiple myeloma patients with double/triple hit cytogenetics on FISH have aggressive presentations, high early mortality...

NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone

PLR was a robust prognostic factor for newly diagnosed early-stage cHL

We conclude that MM survivors who achieve disease control after AHCT have excellent recovery of FACT-BMT and subscale scores to population norms by 1...

CD138+ overexpression of miR-181a was strongly correlated with inferior disease outcome and contributed to superior prediction of MM patients early...

Sono necessari ulteriori studi su questi pazienti ad altissimo rischio per migliorare la gestione della malattia, studi che potrebbero fornire...